ANTIDIABETIC ACTIVITY OF TERMINALIA BELLIRICA ON ALLOXAN INDUCED DIABETIC RATS

被引:0
作者
Surya, C. [1 ]
Sathish, S. [1 ]
Sathya, R. [1 ]
Devi, Nirmala P. [1 ]
Arulmozhi [1 ]
机构
[1] Dhanalakshmi Coll Arts & Sci Women Autonomous, Perambalur, India
来源
INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH | 2021年
关键词
Terminalia bellirica; Phytochemicals; Diabetes mellitus; Lipid profile; EXTRACT;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Diabetes mellitus is one of the common metabolic disorders and 10% of the population. Suffer from this disease throughout the world. Insulin and oral hypoglycemic agents are still the major players in the management of the disease but many adverse effects were, observed and they did not reduce diabetic associated complications. Currently, available treatment is far from satisfactory and is expensive. Many indigenous Indian medicinal plants are successfully used to manage diabetes. Plant drugs are frequently considered to be less toxic and free from side effects than synthetic ones. However, the search for new antidiabetic drugs continues. Keeping this view, the present study aimed to evaluate the anti-diabetic Terminalia bellirica. Administration of Terminalia belliricato AXN rats restored the level of glucose profile. This confirms the antidiabetic activity of Terminalia bellirica. The potential antidiabetic activity of Terminalia belliricais due to the presence of phytochemical constitution present in the plant. Some of these phytochemicals such as Carbohydrates, Free amino acids, Alkaloids, Flavonoids, Tannins, Saponin, Quinones, Glycosides, Cardiac glycosides, Terpenoids, and polyphenolic compounds have possessed antidiabetic activity.
引用
收藏
页码:131 / 134
页数:4
相关论文
共 18 条
  • [1] Aderibigbe A O, 1999, Afr J Med Med Sci, V28, P171
  • [2] ALLAIN CC, 1974, CLIN CHEM, V20, P470
  • [3] Arjun P, 2009, PHARMACOGN MAG, V5, P51
  • [4] Balaraman Ashok Kumar, 2010, Saudi Pharm J, V18, P173, DOI 10.1016/j.jsps.2010.05.009
  • [5] Bihari C. G., 2011, Journal of Pharmacy Research, V4, P28
  • [6] Biradar S. M., 2010, Journal of Pharmacy Research, V3, P2186
  • [7] Bnouham M., 2006, INT J DIABETES MET, V14, P1, DOI [10.1159/000497588, DOI 10.1159/000497588]
  • [8] Buege J.A., 1978, Methods Enzymol, V52, P306
  • [9] Chaturvedi Neelam, 2010, Biochemical and Cellular Archives, V10, P65
  • [10] Definition, epidemiology and classification of diabetes in children and adolescents
    Craig, Maria E.
    Hattersley, Andrew
    Donaghue, Kim C.
    [J]. PEDIATRIC DIABETES, 2009, 10 : 3 - 12